Skip to main content

Table 6 Within group comparison of the secondary outcome measures over time

From: A prospective randomized comparison of the minimally invasive direct anterior and the transgluteal approach for primary total hip arthroplasty

 

Mean (SD)

 

P value

 

P value

 

P value

 

P value

 

Preoperative

6 weeks

3 months

6 months

12 months

XSMFA fi

 Anterior

35.2 (16.1)

21.2 (14.2)

<0.001a

12.7 (12.5)

<0.001a

11.6 (12.1)

0.895a

10.3 (13.0)

1.000a

 Lateral

40.5(16.0)

28.5(15.9)

<0.001a

18.8 (16.1)

<0.001a

15.8 (15.4)

0.037a

15.1 (16.3)

1.000a

XSMFA bi

 Anterior

48.7 (20.5)

26.6 (19.8)

<0.001a

19.8 (17.0)

0.005a

16.8 (15.8)

0.510a

15.8 (18.0)

1.000a

 Lateral

53.0 (17.9)

33.0 (18.3)

<0.001a

33.0 (18.1)

0.021a

25.1 (17.9)

0.125a

21.7 (19.6)

1.000a

T25-FW

 Anterior

22.4 (5.2)

21.3(6.3)

0.743a

18.5 (3.7)

0.048a

18.3 (4.1)

1.000a

18.1 (3.4)

1.000a

 Lateral

24.0 (3.9)

22.0 (4.2)

0.652a

19.4 (3.8)

0.049a

19.9 (5.5)

1.000a

19.8 (4.6)

1.000a

Activity VAS

 Anterior

5.0 (0.8)

6.9 (0.7)

<0.001a

7.3 (0.8)

1.000a

7.3 (0.7)

1.000a

7.5 (0.6)

1.000a

 Lateral

4.9 (0.8)

6.8 (0.6)

<0.00a

6.9 (0.5)

1.000a

6.9 (0.7)

1.000a

7.0 (0.7)

1.000a

SF-36 PCS

 Anterior

27.4 (8.2)

39.1 (9.7)

<0.001a

44.6 (9.2)

<0.001a

46.0 (10.0)

1.000a

47.5 (9.9)

1.000a

 Lateral

25.6 (8.7)

34.8 (9.8)

<0.001a

40.7 (10.1)

0.001a

42.7 (5.6)

0.277a

42.9 (11.9)

1.000a

SF-36 MCS

 Anterior

57.2 (8.5)

58.1 (8.7)

1,000a

56.0 (9.2)

1.000a

56.0 (10.0)

1.000a

55.0 (9.8)

1.000a

 Lateral

56.3 (9.2)

59.3 (6.6)

0.931a

56.7 (8.3)

1.000a

55.8 (7.2)

1.000a

56.2 (6.9)

1.000a

  1. SD standard deviation
  2. a Friedman test